| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |